In my role as a Partner at Summa Equity, I collaborate closely with the investment team and together we develop investment strategies, identify and assess investment opportunities, and support our portfolio companies in helping them to develop their full potential. My primary focus is on both healthcare and technology, with the crossroads of both arguably being one of the most exciting domains.
I consider working as a Partner for Summa Equity as a unique opportunity to create tangible impact in terms of sustainable economic development, contribute to a long-term defendable and successful investment philosophy, work with the impressive Summa team and leverage my entrepreneurial experience. That’s not just fun, it’s also highly satisfying to tackle global challenges.
All of my career has been in technology with initially a strong focus on financial technology, including trading, cash management, and payments. The last 10 years before joining Summa have been in life sciences, more specifically genomics and multi-omics data analytics with BlueBee (acquired by Illumina). I have been the co-founder and CEO for several successful start-ups and alternated between these entrepreneurial initiatives and senior executive rules in global corporations, including Alcatel Lucent, Sungard FIS, SWIFT, and most recently as the VP of Software for Illumina.